sarcopenie - hogeschool van amsterdam · 10-40% fat mass ling et al., j nutr 2011; ling et al., age...
TRANSCRIPT
![Page 1: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/1.jpg)
“Sarcopenie”Dr. Carel Meskers, revalidatiearts
![Page 2: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/2.jpg)
Kehoe et al. Emerg Med J 2015;32:911-915
%
Medical revolution
![Page 3: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/3.jpg)
Life expectancy at 65 years
![Page 4: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/4.jpg)
GENETIC (“BRAND”)
Bad luck
Lifestyle (use, maintenance)
![Page 5: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/5.jpg)
The medical challenge…
![Page 6: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/6.jpg)
640 muscles
contraction = movement
glucose metabolisme
protein storage
Modifyable!
Vesalius
Muscle
![Page 7: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/7.jpg)
640 muscles
contraction = movement
glucose metabolisme
protein storage
Modifyable!
Vesalius
Muscle
![Page 8: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/8.jpg)
Morgan Int J Biochem Cell Bio, 2003
![Page 9: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/9.jpg)
sarx flesh penia deminished
•
•
low skeletal muscle mass
Sarcopenia
![Page 10: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/10.jpg)
21 jr 63 jr
![Page 11: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/11.jpg)
21 jr 63 jr
Sarcopenie is een ziekte
![Page 12: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/12.jpg)
FP7, MYOAGE
![Page 13: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/13.jpg)
Grip strength
Quadriceps strength
Muscle strength
![Page 14: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/14.jpg)
45-90% lean mass
10-40% fat mass
Ling et al., J Nutr 2011; Ling et al., Age 2011
Muscle mass
![Page 15: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/15.jpg)
Te mager?
Sarcopeen?
![Page 16: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/16.jpg)
Te dik- verlies van spiermassa?
Sarcopeen? Sarcopeen?
![Page 17: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/17.jpg)
Beenakker et al., Ageing Res Rev, 2010
Cruz Jentoft et al. 2018
meta-regression lines with 95% confidence
band (adjusted to 50% female)
General population
20 40 60 80 1000
10
20
30
40
50
60
Age (years)
Gri
p s
tren
gth
(k
g)
![Page 18: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/18.jpg)
89 years
HR 3.7, CI 2.5-5.7
HR 2.6, CI 1.6-4.4
Muscle strength and survival
Ling et al., CMAJ 2009
![Page 19: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/19.jpg)
![Page 20: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/20.jpg)
Harimoto., Brit J Surg 2013
196 pt hepatocellular carcinoma undergoing hepatectomy, CT L3, 40% sarcopenic
Hepatocellular carcinoma - survival
![Page 21: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/21.jpg)
15
17
19
21
23
25
27
Mean
han
dg
rip
str
en
gth
[kg
]
Lowest tertile Middle tertile Highest tertile
MMSE 85 years MMSE 89 years
both p for trend < 0.001
Taekema et al. 2011
Muscle strength and cognition
![Page 22: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/22.jpg)
SPIERMASSA (DEXA) GLUCOSE METABOLISME
Bijlsma et al. AGE 2013
4.0
4.5
5.0
**
Ln
In
su
lin
AU
C
Low Moderate High4.0
4.5
5.0
**
Low Moderate High13
14
15
16
17 **
ALM percentage in tertiles(Relative muscle measure)
Glu
co
se A
UC
Low Moderate High13
14
15
16
17
ALM/Height2 in tertiles
(Absolute muscle measure)
NS
A. B.
C. D.
![Page 23: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/23.jpg)
1
(1A) Study design
(1B) Study population
Yeung et al. 2018
Consistent associationsarcopenia and falls
![Page 24: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/24.jpg)
Sarcopenia predicts
detrimental outcome.
![Page 25: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/25.jpg)
Reijnierse et al. 2015, Gerontology; Bijlsma et al. 2012, Age
Used definitions
![Page 26: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/26.jpg)
Reijnierse et al. 2015, Gerontology; Bijlsma et al. 2012, Age
Used definitions
![Page 27: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/27.jpg)
‘Concordance’ sarcopenia
Older adults
Prevalence 2% to 34%
Reijnierse et al. 2015, Gerontology
![Page 28: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/28.jpg)
Prevalence of sarcopenia is highly dependent on the applied set of diagnostic
criteria.
![Page 29: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/29.jpg)
Cruz-Jentoft et al., Age Ageing 2010
European consensus EWGSOP I
![Page 30: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/30.jpg)
Cruz Jentoft et al. 2018
EWGSOP II
![Page 31: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/31.jpg)
![Page 32: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/32.jpg)
Sarcopenia predicts
detrimental outcome.
‘Consensus like situation’.
![Page 33: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/33.jpg)
![Page 34: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/34.jpg)
Review Cruz-Jentoft 2014
• > 50 years, community dwelling
• 7 studies (2000-2013)
• Median quality
• Resistance training may improving musclestrength and physical performance
• Time of intervention of at least 3 monthsand probably longer
Cruz Jentoft et al. 2014
![Page 35: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/35.jpg)
Progressive resistance training-recommendations
Per week 150 min. moderate or 60 min. high intensity
Intensity: experienced load 5-6/10 of 7-8/10 Borg
3 or more times a week.
8-10 whole body excercises.
Most important muscle groups of legs, hips, chest, back, belly, shoulders and arms.
8-12 repetitions per muscle group.
2 minutes of rest between excercises.
Montero-Fernandez 2013. Eur. J. Phys Rehab Med.; 49 -1
![Page 36: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/36.jpg)
Progressive resistancetrainingmuscle volume (CSA) and satellite cells
![Page 37: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/37.jpg)
Table 2. The association between malnutrition and standardized measures of physical performance in geriatric outpatients
referred to mobility clinics (n= 286)
Z HGS Z LN CST Z Gait speed Z LN TUG Z SPPB Score Side by side Semi-tandem Tandem
Crude
β (95% CI) -0.27 (-0.58,
0.04)
0.52 (0.18, 0.86) -0.56 (-0.86, -
0.25)
0.37 (0.03,
0.72)
-0.42 (-0.74, -
0.11)
0.66 (0.25,
1.76)
0.67 (0.33,
1.34)
0.97 (0.51,
1.80)
p-value 0.083* 0.003 0.000 0.034 0.008 0.406 0.251 0.913
β x SD -2.42 -5.05 -0.16 5.63 -1.37 -- -- --
Model adjusted for age, sex, and multimorbidity
β (95% CI) -0.24 (-0.54,
0.07)
0.53 (0.19, 0.87) -0.49 (-0.78,
0.20)
0.37 (0.03,
0.70)
-0.40 (-0.70, -
0.10)
0.69 (0.23,
2.02)
0.67
(0.31,1.43)
1.02 (0.51,
2.04)
p-value 0.131 0.003 0.001 0.032 0.009 0.497 0.294 0.957
β x SD -2.15 -5.15 -0.14 5.63 -1.30 -- -- --
*Statistically significant results are presented in bold. SPPB = short physical performance battery; CST = chair stand test; TUG = timed up and go; HGS = handgrip
strength; β = beta; CI = confidence interval.
**All measures of physical performance were standardized and presented as gender specific z-scores.
***Interpretation: The β represents the average difference between participants with the presence of malnutrition on physical performance standard deviations (SD),
compared to outpatients without malnutrition. β coefficients were transformed from units of SD to the physical performance measures’ original units by using the
equation β x SD.
N=286 geriatric outpatients
Ramsey et al. In preparation
Nutritional state & physical performance are associated
![Page 38: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/38.jpg)
Table 2. The association between malnutrition and standardized measures of physical performance in geriatric outpatients
referred to mobility clinics (n= 286)
Z HGS Z LN CST Z Gait speed Z LN TUG Z SPPB Score Side by side Semi-tandem Tandem
Crude
β (95% CI) -0.27 (-0.58,
0.04)
0.52 (0.18, 0.86) -0.56 (-0.86, -
0.25)
0.37 (0.03,
0.72)
-0.42 (-0.74, -
0.11)
0.66 (0.25,
1.76)
0.67 (0.33,
1.34)
0.97 (0.51,
1.80)
p-value 0.083* 0.003 0.000 0.034 0.008 0.406 0.251 0.913
β x SD -2.42 -5.05 -0.16 5.63 -1.37 -- -- --
Model adjusted for age, sex, and multimorbidity
β (95% CI) -0.24 (-0.54,
0.07)
0.53 (0.19, 0.87) -0.49 (-0.78,
0.20)
0.37 (0.03,
0.70)
-0.40 (-0.70, -
0.10)
0.69 (0.23,
2.02)
0.67
(0.31,1.43)
1.02 (0.51,
2.04)
p-value 0.131 0.003 0.001 0.032 0.009 0.497 0.294 0.957
β x SD -2.15 -5.15 -0.14 5.63 -1.30 -- -- --
*Statistically significant results are presented in bold. SPPB = short physical performance battery; CST = chair stand test; TUG = timed up and go; HGS = handgrip
strength; β = beta; CI = confidence interval.
**All measures of physical performance were standardized and presented as gender specific z-scores.
***Interpretation: The β represents the average difference between participants with the presence of malnutrition on physical performance standard deviations (SD),
compared to outpatients without malnutrition. β coefficients were transformed from units of SD to the physical performance measures’ original units by using the
equation β x SD.
N=286 geriatric outpatients
Ramsey et al. In preparation
Nutritional state & physical performance are associatedSNAQ score
![Page 39: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/39.jpg)
Protein intake and loss of musclemass
Houston D K et al. Am J Clin Nutr 2008;87:150-155. Ouderen 70-79 jaar.
0,7 0,7 0,8 0,9 1,1 g/kg/day
40% less
loss of
muscle
Afn
am
e in
spie
rma
ssa (kg
)
![Page 40: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/40.jpg)
44
Paddon-Jones, Curr Opin Clin Nutr Metab Care. 2009, Jan;12(1):86-
90. Review.
Optimal protein synthesis at 25-30 grams protein per meal
![Page 41: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/41.jpg)
Extra protein (during breakfast and lunch) + resistance training
Tieland et al., JAMDA 2012
Fa
t fr
ee
ma
ss
Increase in muscle mass
![Page 42: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/42.jpg)
Resistance training and protein supplementation-effect on fat free mass
Cermak et al. AJCN 2012
![Page 43: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/43.jpg)
Sarcopenia predicts
detrimental outcome.
‘Consensus like situation’.
Targeted intervention,
including the old!
Multidisciplinary diagnosis&
treatment
![Page 44: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/44.jpg)
70 years, hazard ratio for the development of disability after
hospitalisation : 61.8
Gill et al JAMA. 2004 Nov 3;292(17):2115-24.
![Page 45: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/45.jpg)
The Empower study
Inception cohort study
• Elderly aged >70
• Admitted to VU Medial Center
• From April to December 2015
• Minimal inclusion criteria.
Predictive value of muscle mass and handgrip strength at
admission and discharge in hospitalized older adults.
![Page 46: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/46.jpg)
N-3
85
ADMISSION DISCHARGE 3 MONTHS
Muscle mass
Strength
ADL
SPBB
SNAQ
#Falls
6-CIT
Muscle mass
Strength
ADL
SPBB
SNAQ
ADL
# Falls
Mortality
Study design (n=385)
![Page 47: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/47.jpg)
• Muscle strength: handgrip strenght
• Muscle mass: Bio Impedance Analyzer
![Page 48: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/48.jpg)
Ancum et al., 2017, Pierik et al 2017
In elderly hospitalized patients
At admission:
•HGS /muscle mass with physical disability (ADL).
•HGS /muscle mass with # falls
•HGS/ muscle mass with cognition
•HGS/ muscle mass with geriatric risk factors
![Page 49: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/49.jpg)
Ancum et al. Gerontology 2017
![Page 50: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/50.jpg)
Ancum et al. Exp Gerontology 2017
![Page 51: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/51.jpg)
Rehab: literature review
Scheerman et al. submitted
Stimulation of physical performance and
physical activity in older patients during
hospitalization: a systematic review.
Inclusion critera
•Hospitalized older patients with a mean age of 65 years
and older,
•Physical interventions with physical performance or
physical activity as outcome measures
![Page 52: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/52.jpg)
Literature review
Scheerman et al. submitted
Stimulation of physical performance and
physical activity in older patients during
hospitalization: a systematic review.
• Twelve RCT’s
• Large heterogenity in applied interventions, dose and
outcome measures.
• Insufficient report on dose
![Page 53: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/53.jpg)
Literature review
Scheerman et al. submitted
Stimulation of physical performance and
physical activity in older patients during
hospitalization: a systematic review.
• Evidence of positive effect of patient- tailored
interventions on muscle measures and physical
performance
• No evidence of effect of non- patient tailored
intervention
Patient tailored= Physical interventions
adapted to the capabilities of the patient
![Page 54: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/54.jpg)
Verlaan et al. J Frailty Aging 2017
Follow- up (3 months)
![Page 55: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/55.jpg)
Disability thresholdSY
ST
EM
DE
CLIN
E
Age
Hospital admission
?
• LoS
• Phenotype
• Acute/ non acute
• Surgical/ non surgical
• Premorbid state
![Page 56: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/56.jpg)
ADDITIONAL
TRAINING
NORMAL ACTIVE
SEDENTARY
(BED REST) BENEFITS?
BENEFITS?
![Page 57: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/57.jpg)
Schrack e.a. 2014
Act
ivit
eit
`leeftijd
![Page 58: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/58.jpg)
Relationship between dose of moderate-to-vigorous-intensity physical activity (MVPA) and
mortality reduction.
David Hupin et al. Br J Sports Med 2015;49:1262-1267
Copyright © BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine. All rights reserved.
22% minder sterfte
![Page 59: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/59.jpg)
Act
ivit
eit
12u ‘s nachts 8 uur ‘s ochtends 4 uur ‘s middags 12u ‘s avonds
74 jaar en ouder
60 jaar en jonger
Schrack et al 2014
![Page 60: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/60.jpg)
• Vermoeidheid?
• “Het hoort erbij”
• Gebrek aan activiteiten buiten de deur
• Gewoonte/angst.
• Omgeving?
![Page 61: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/61.jpg)
SPIER BEWEGING/ACTIVITEIT
![Page 62: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/62.jpg)
WIJZELF BEWEGING/ACTIVITEIT OMGEVING
![Page 63: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/63.jpg)
![Page 64: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/64.jpg)
![Page 65: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/65.jpg)
PERSOON OMGEVING
Rantakokko et al. 2013
Aantal barrieresSterfte
![Page 66: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/66.jpg)
![Page 67: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/67.jpg)
• Maak het leuk
• Niet te snel te simpel
• Inpassen
• Aanpassen
Lichamelijk actief?
![Page 68: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/68.jpg)
MACH Submission to the MRFF – January 2017 2
randomized clinical trials with short and long term outcomes (WP2);
3) Understanding: of basic biological mechanisms in humans leading to novel interventions being tested within the trial network (WP3);
4) Implementation: of diagnostic strategies and interventions as usual care in geriatric rehabilitation settings (WP4);
5) Dissemination: encouraging screening, diagnostics and intervention on regional, national and international level to expand access to sarcopenia treatments in collaboration with national and international stakeholders (WP5).
6. Project description
The opportunity In geriatric rehabilitation care there is a lack of evidence regarding the epidemiology and treatment of sarcopenia, particularly the benefits of exercise and nutritional interventions. Furthermore, the lack of understanding of biological mechanisms driving sarcopenia in conjunction with other age-related diseases has hindered the development of novel interventions. Highlighting this gap between science and practice, very few healthcare professionals use diagnostic measures or apply appropriate interventions for sarcopenia in clinical practice. EMPOWER-GR will address these issues.
The solution This proposal contains an observational longitudinal multicentre cohort (WP1) of geriatric rehabilitation patients to characterise the epidemiology of sarcopenia stratified by main admission diagnoses (trauma, stroke, infectious disease and cardiopulmonary). Patients will be recruited over six months and followed-up for six months. In 2015-16, 2300 patients were admitted to the participating health care organizations. With an anticipated inclusion rate of 70%, 805 patients are expected to be enrolled. Sarcopenia will be diagnosed based on the EWGSOP criteria5 and health domains (physical, cognitive, and social) will be tested using standardised protocols.
As physical inactivity and protein malnutrition are implicated to be key modifiable causes of sarcopenia, a multicentre, single blinded, cluster randomized clinical trial (WP2) will be conducted (Figure 1). The trial will enrol 180 orthogeriatric patientsi (including both elective and acute orthopaedics (trauma)) admitted to geriatric rehabilitation6-8. The primary endpoint at three months will be lean mass (kg/m2). Secondary endpoints include living independently, muscle strength, physical performance/activity and quality of life. EMPOWER-GR will also assess cost effectiveness of the intervention based on health care utilisation. Mechanistic endpoints include change in myostatin levels, senescent cell load and markers for muscle quality9-11. The physical exercise training will consist of progressive resistance training12-14 three times a week (60% to 80% of 1RM within three weeks). The institutional program will be continued by a strength enhancing exercise program
i Sample size is based on 1.14 kg (SD 1.4 kg) lean mass difference between intervention and control in a community dwelling population.
Taking a larger heterogeneity of our population, the correction for clusters and a loss of follow up of 25% into account, a sample size of 90 patients per group (one to one ratio) is considered.
Figure 1: Study design of
the EMPOWER-GR RCT
![Page 69: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/69.jpg)
Life trajectories
![Page 70: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/70.jpg)
Life trajectories
![Page 71: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/71.jpg)
Life trajectories
![Page 72: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/72.jpg)
• Care_4_muscles:
o Motor – physical function
o Internal organ- health
• Strength training & nutritional state/proteins
• Risks of life events
• Balanced physical activity & Environmental
challenges
![Page 73: Sarcopenie - Hogeschool van Amsterdam · 10-40% fat mass Ling et al., J Nutr 2011; Ling et al., Age 2011 Muscle mass. Te mager? Sarcopeen? Te dik- verlies van spiermassa? Sarcopeen?](https://reader034.vdocuments.us/reader034/viewer/2022043000/5f765b2eeaee724dd5409bbb/html5/thumbnails/73.jpg)